Articles
2013 Eureka Prize winners
From diamonds that light up the inside of cells to broody male weedy sea dragons, this year's Australian Museum Eureka Prizes recognise some of the great work and great people in Australian science. [ + ]
Seagrass provides blue carbon reserve
As well as being a favourite feeding ground for dugongs and sea turtles, seagrass meadows may be a major carbon sink for the planet. [ + ]
GI Dynamics extends Australian reach of EndoBarrier
GI Dynamics (ASX:GID) said five new centres in Australian capital cities have agreed to offer EndoBarrier as a treatment option for type 2 diabetes and obesity. [ + ]
Why does jet-lag recovery lag?
Researchers at the University of Oxford, University of Notre Dame and F Hoffmann-La Roche have identified a mechanism that limits the ability of the body clock to adjust to changes in patterns of light and dark. This in turn reveals why the body is so slow to recover from jet lag. [ + ]
Clinuvel posts follow-up data from vitiligo trial
During a recent trial, Clinuvel's Scenesse (ASX:CUV) was able to improve repigmentation in patients undergoing NB-UVB therapy for vitiligo, and to help sustain the effect. [ + ]
Breeding sorghum to feed the world
Whole genome resequencing reveals sorghum contains much more genetic variation than previously realised. [ + ]
Uncovering the best cab sav clones
The local wine industry and consumers will both benefit following research to identify differences in the top cabernet sauvignon grape clones. [ + ]
Why taller people are smarter
It hardly seems fair but people who are attractive because of one trait tend to have other attractive traits as well. [ + ]
FDA knocks back QRxPharma's MoxDuo again
QRxPharma (ASX:QRL) will need to resubmit its FDA application for MoxDuo IR again, after the regulator issued a second Complete Response Letter. [ + ]
Allied Healthcare gets CE Mark for CardioCel
After securing regulatory approval, Allied Healthcare (ASX:AHZ) now expects to start selling its CardioCel heart patch in Europe in calendar Q4. [ + ]
University of Adelaide ‘braggs’ about transdisciplinary facility
In July 2013, following the award of $29 million from the Education Investment Fund, ‘The Braggs’ was officially opened. Named after University of Adelaide alumni Sir William Henry Bragg and his son, Sir William Lawrence Bragg, the $100 million building is the home of the Institute for Photonics and Advanced Sensing (IPAS). [ + ]
Hypertension drugs increase the effect of chemo in childhood cancer
Beta-blockers are traditionally used in the treatment of high blood pressure, but researchers at the Children’s Cancer Institute Australia (CCIA) have found that they can also increase the effectiveness of chemotherapy in treating aggressive childhood cancers such as neuroblastoma. [ + ]
Ascend gears up for cancer immunotherapy trials
Ascend Biopharmaceuticals CEO Clement Leong details the company’s plans for Australian clinical trials of its key products, a cancer vaccine and an oncolytic virus. [ + ]
Trials in autoimmune disease
Giving children their own cord blood to prevent them getting type 1 diabetes and development of a new immunotherapy are part of a more tailored approach to treating autoimmune diseases. [ + ]
Prime Minister announces Medical Technologies Innovation Partnership
Prime Minister Kevin Rudd last week announced the Medical Technologies Innovation Partnership - the first of the Australian Innovation Partnership program. The program is intended to create partnerships between government, business and the research community that will create new high-skill jobs for the future. [ + ]